Journal of Cardiovascular Disease Research
Correlation of HbA1c and dyslipidemia in patients of CKD
Dr. Pallavi Anand, Dr. Chandan Kumar, Dr. Pankaj Hans, Dr. S. Ahmed
JCDR. 2022: 3253-3264
Abstract
The frequency of chronic kidney disease (CKD), a serious health issue, is rising globally, especially in those with metabolic diseases such dysglycemia disorders. The glycated hemoglobin concentration (HbA1c) can reveal dysglycemia diseases, such as the prediabetic state, while also serving as a valuable indicator of mean blood glucose levels during the previous three months.Although it is not always present, dyslipidemia (DLP) is a frequent consequence of increasing renal disease. Elevated triglyceride levels, low HDL cholesterol, and small, dense LDL particle size are characteristics of DLP, a renal and cardiovascular risk factor.
» PDF